PagnatoKarp Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-59,992
| Closed | -$1.86M | – | 103 |
|
|
2020
Q1 | $1.86M | Buy |
59,992
+1,565
| +3% | +$48.5K | 0.46% | 37 |
|
|
2019
Q4 | $2.17M | Buy |
58,427
+178
| +0.3% | +$6.62K | 0.38% | 40 |
|
|
2019
Q3 | $1.99M | Sell |
58,249
-320
| -0.5% | -$10.9K | 0.39% | 40 |
|
|
2019
Q2 | $2.41M | Sell |
58,569
-1,786
| -3% | -$73.4K | 0.51% | 33 |
|
|
2019
Q1 | $2.43M | Buy |
60,355
+8,892
| +17% | +$358K | 0.54% | 34 |
|
|
2018
Q4 | $2.13M | Sell |
51,463
-4,372
| -8% | -$181K | 0.45% | 39 |
|
|
2018
Q3 | $2.34M | Buy |
55,835
+4,465
| +9% | +$187K | 0.68% | 27 |
|
|
2018
Q2 | $1.77M | Buy |
51,370
+6,735
| +15% | +$232K | 0.56% | 30 |
|
|
2018
Q1 | $1.5M | Sell |
44,635
-1,039
| -2% | -$35K | 0.63% | 28 |
|
|
2017
Q4 | $1.57M | Sell |
45,674
-944
| -2% | -$32.4K | 0.46% | 29 |
|
|
2017
Q3 | $1.58M | Buy |
46,618
+1,243
| +3% | +$42.1K | 0.4% | 27 |
|
|
2017
Q2 | $1.45M | Buy |
45,375
+752
| +2% | +$24K | 0.44% | 31 |
|
|
2017
Q1 | $1.45M | Buy |
44,623
+1,069
| +2% | +$34.7K | 0.42% | 31 |
|
|
2016
Q4 | $1.34M | Buy |
+43,554
| New | +$1.34M | 0.4% | 37 |
|